|
시장보고서
상품코드
2008042
기억력 향상약 시장 : 약제 클래스별, 투여 경로별, 적응별, 유통 채널별, 지역별Memory Enhancement Drugs Market, By Drug Class, By Route of Administration, By Application, By Distribution Channel, By Geography |
||||||
기억력 향상약 시장은 2026년에 98억 2,360만 달러로 추정되고 있으며, 2033년까지 142억 5,250만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 5.5%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 98억 2,360만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년의 예측 기간 CAGR : | 5.50% | 2033년 시장 규모 예측 : | 142억 5,250만 달러 |
기억력 개선제는 노화나 중추신경계(CNS) 외상으로 인한 기억력 장애를 앓고 있는 사람들을 치료하는 데 사용됩니다. 알츠하이머병은 기억력 장애의 발병과 인지 기능의 저하를 계기로 시작될 수 있습니다. 외상, 특히 뇌의 외상으로 인해 뇌세포가 사멸하는 것은 빈번하게 발생하지만, 노화에 따른 기억력 장애는 정상적인 현상이며, 기억력을 향상시키는 약물로 치료가 가능합니다.
규제 당국이 승인한 기억력 개선제의 시장에서의 존재감은 낮지만, 그 효과를 검증하기 위한 몇 가지 임상 시험이 진행되고 있습니다. 현재 이용 가능한 기억력 개선제의 대부분은 비타민, 항산화제, 지질 등 식이유래의 기억력 개선제입니다. 또한 세계 각국의 규제 당국도 의료용으로 기억력을 향상시키는 신약을 승인하고 있습니다. 리탈린과 아데랄은 기억력 개선제로 사용되는 적응증 외 약물의 두 가지 예입니다. 인지기능 및 기억력 향상제나 외부 보충제의 목적은 동기부여, 창의력, 기억력 등 실행 기능을 포함한 개인의 인지 능력을 향상시키는 데 있습니다. 이 약들은 인지기능을 최고 수준으로 유지하기 어려운 환자들에게 처방됩니다. 또한 알츠하이머병, 정신분열증, 망상증, 주의력결핍장애(ADD) 등 정신질환을 앓고 있는 환자들에게 증상 대처를 돕기 위해 사용되고 있습니다.
시장 역학
시장에서 활동하는 주요 기업은 기억력 개선제의 임상 시험 횟수를 늘리는 데 주력하고 있습니다. 예를 들어 2020년 1월 Journal of Biomed Science에 게재된 논문에 따르면 연구자들은 현재 항아밀로이드 및 항타우, 신경전달물질 조절, 항신경염증 및 신경보호, 인지기능 개선, 행동 및 심리적 증상 완화 등 다양한 표적을 가진 잠재적 치료법을 시험하고 있습니다. 다양한 표적을 가진 수많은 잠재적 치료법을 시험하고 있습니다.
본 조사의 주요 특징.
- 이 보고서는 세계 기억력 향상제 시장에 대한 상세한 분석을 제공하며, 2021년을 기준연도로 하여 예측 기간(2022-2030년) 시장 규모와 연평균 성장률(CAGR%)을 제시합니다.
- 이 보고서는 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 이 보고서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트도 제공합니다.
- 이 보고서는 회사 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등 다양한 매개 변수를 기반으로 세계의 기억력 향상제 시장의 주요 기업을 분석합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 기억력 향상제 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 기억력 향상약 시장 : 약제 클래스별, 2026-2033년
제5장 세계의 기억력 향상약 시장 : 투여 경로별, 2026-2033년
제6장 세계의 기억력 향상약 시장 : 적응별, 2026-2033년
제7장 세계의 기억력 향상약 시장 : 유통 채널별, 2026-2033년
제8장 세계의 기억력 향상약 시장 : 지역별, 2026-2033년
제9장 경쟁 구도
제10장 섹션
KSA 26.04.30Memory Enhancement Drugs Market is estimated to be valued at USD 9,823.6 Mn in 2026 and is expected to reach USD 14,252.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 9,823.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.50% | 2033 Value Projection: | USD 14,252.5 Mn |
Drugs that improve memory are used to treat people who have memory loss as a result of age or traumatic injury to the central nervous system (CNS). Alzheimer's disease may begin as a result of the onset of memory loss or a decline in cognition. Brain cells frequently die as a result of trauma, particularly to the brain, and although memory loss is normal as people age, it is treatable with medications that improve memory.
Despite the low market presence of regulatory authorities-approved memory-enhancing medications, several clinical trials are being conducted to examine the results. The majority of currently available medications that improve memory come from diet, such as vitamins, antioxidants, lipids, etc. Different countries of the world have also approved new medications that improve memory for medical use. Ritalin and Adderall are two examples of off-label medications that are being used as memory boosters. The goal of cognitive and memory enhancement medications and external supplements is to increase a person's cognitive capacity, which includes executive functions like motivation, creativity, and memory. These medications are prescribed to patients who have trouble sustaining their cognitive functions at their peak levels. These medications are used to treat patients with mental health conditions such Alzheimer's, schizophrenia, paranoia, and attention deficit disorder (ADD) in order to assist them cope with the ailment's symptoms.
Market Dynamics
Key players operating in the market are focused on increasing number of clinical trials for memory enhancement drugs. For instance, according to an article published in January 2020, on Journal of Biomed Science, researchers are currently testing a number of potential treatments with various targets, including anti-amyloid and anti-tau, neurotransmitter modification, anti-neuroinflammation and neuroprotection, cognitive enhancement, and treatments to relieve behavioral and psychological symptoms.
Key features of the study
- This report provides an in-depth analysis of the global memory enhancement drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global memory enhancement drugs market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies.
- Key companies covered as a part of this study Pfizer Inc., UCB S.A., Takeda Pharmaceutical Company, Shire plc. Sanochemia Pharmazeutika AG, Allergan plc., Novartis AG, Alkem Laboratories Ltd., Paradigm Healthcare, Intas Pharmaceutical Ltd., Taurus Laboratories Pvt. Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global memory enhancement drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global memory enhancement drugs market.
Market Segmentation
- Global Memory Enhancement Drugs Market, By Drug Class
- Cholinesterase Inhibitors
- Smart Drugs and Cognitive Enhancers (Nootropics)
- Vitamins and Supplements
- Others
- Global Memory Enhancement Drugs Market, By Route of Administration
- Oral
- Injectable
- Topical
- Global Memory Enhancement Drugs Market, By Application
- Disease treatment
- Athletic performance
- Academic performance
- Others
- Global Memory Enhancement Drugs Market, By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Global Memory Enhancement Drugs Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players
- Pfizer Inc.
- UCB S.A.
- Takeda Pharmaceutical Company
- Shire plc.
- Sanochemia Pharmazeutika AG
- Allergan plc.
- Novartis AG
- Alkem Laboratories Ltd.
- Paradigm Healthcare
- Intas Pharmaceutical Ltd.
- Taurus Laboratories Pvt. Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Regulatory Scenario
- Market Trends
- Pipeline Analysis
- Key Developments
- Epidemiology
- PEST Analysis
4. Global Memory Enhancement Drugs Market, By Drug Class, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2030 (%)
- Y-o-Y Growth Analysis, 2022 - 2030
- Segment Trends
- Cholinesterase Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Smart Drugs and Cognitive Enhancers (Nootropics)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Vitamins and Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
5. Global Memory Enhancement Drugs Market, By Route of administration, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2030 (%)
- Y-o-Y Growth Analysis, 2022 - 2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
6. Global Memory Enhancement Drugs Market, By Application, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2030 (%)
- Y-o-Y Growth Analysis, 2022 - 2030
- Segment Trends
- Disease treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Athletic performance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Academic performance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Others
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2026 - 2030
- Segment Trends
7. Global Memory Enhancement Drugs Market, By Distribution Channel, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2030 (%)
- Y-o-Y Growth Analysis, 2022 - 2030
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
8. Global Memory Enhancement Drugs Market, By Region, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2026-2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026-2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- UCB S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Shire plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanochemia Pharmazeutika AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Allergan plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- . Alkem Laboratories Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Paradigm Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Intas Pharmaceutical Ltd.,
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Taurus Laboratories Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc
10. Section
- Research Methodology
- About us
